Sarissa Capital Management

Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are INVA, NBIX, CYTK, IRWD, AMRN, and represent 92.85% of Sarissa Capital Management's stock portfolio.
  • Added to shares of these 3 stocks: LNTH, REGN, Vor Biopharma.
  • Started 2 new stock positions in REGN, Vor Biopharma.
  • Reduced shares in these 1 stock: VOR.
  • Sold out of its position in VOR.
  • Sarissa Capital Management was a net buyer of stock by $7.1M.
  • Sarissa Capital Management has $180M in assets under management (AUM), dropping by 16.84%.
  • Central Index Key (CIK): 0001577524

Tip: Access up to 7 years of quarterly data

Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Sarissa Capital Management

Sarissa Capital Management holds 8 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Innoviva (INVA) 28.5 $51M 2.8M 18.25
 View chart
Neurocrine Biosciences (NBIX) 23.6 $43M 303k 140.38
 View chart
Cytokinetics Com New (CYTK) 17.9 $32M 588k 54.96
 View chart
Ironwood Pharmaceuticals Com Cl A (IRWD) 11.6 $21M 16M 1.31
 View chart
Amarin Corp Sponsored Adr (AMRN) 11.3 $20M 1.2M 16.38
 View chart
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 5.2 $9.3M +88% 182k 51.29
 View chart
Regeneron Pharmaceuticals (REGN) 1.3 $2.4M NEW 4.2k 562.27
 View chart
Vor Biopharma Com New 0.7 $1.2M NEW 25k 48.72
 View chart

Past Filings by Sarissa Capital Management

SEC 13F filings are viewable for Sarissa Capital Management going back to 2013

View all past filings